Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure

Graber-Stiehl, 2018, The silent epidemic killing more people than HIV, malaria or TB, Nature, 564, 24, 10.1038/d41586-018-07592-7 Liang, 2015, Present and future therapies of hepatitis B: from discovery to cure, Hepatology, 62, 1893, 10.1002/hep.28025 Nassal, 2015, HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B, Gut, 64, 1972, 10.1136/gutjnl-2015-309809 Yim, 2006, Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005, Hepatology, 43, S173, 10.1002/hep.20956 Lok, 2017, Hepatitis B cure: from discovery to regulatory approval, J Hepatol, 67, 847, 10.1016/j.jhep.2017.05.008 Terrault, 2018, Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance, Hepatology, 67, 1560, 10.1002/hep.29800 Fanning, 2019, Therapeutic strategies for hepatitis B virus infection: towards a cure, Nat Rev Drug Discov, 18, 827, 10.1038/s41573-019-0037-0 Lok, 1987, Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection, Gastroenterology, 92, 1839, 10.1016/0016-5085(87)90613-5 Lai, 1998, A one-year trial of lamivudine for chronic hepatitis B: Asia Hepatitis Lamivudine Study Group, N Engl J Med, 339, 61, 10.1056/NEJM199807093390201 Hadziyannis, 2003, Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B, N Engl J Med, 348, 800, 10.1056/NEJMoa021812 Ghany, 2009, Antiviral resistance and hepatitis B therapy, Hepatology, 49, S174, 10.1002/hep.22900 Wong, 2018, Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B, Aliment Pharmacol Ther, 47, 730, 10.1111/apt.14497 Honda, 2017, Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B, Clin Microbiol Infect, 23, 407 e1, 10.1016/j.cmi.2016.12.014 Nishitsuji, 2015, Novel reporter system to monitor early stages of the hepatitis B virus life cycle, Cancer Sci, 106, 1616, 10.1111/cas.12799 Murayama, 2021, N-terminal PreS1 sequence regulates efficient infection of cell-culture-generated hepatitis B virus, Hepatology, 73, 520, 10.1002/hep.31308 Yuan, 1999, Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen, J Virol, 73, 10122, 10.1128/JVI.73.12.10122-10128.1999 Bartenschlager, 1990, The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation, J Virol, 64, 5324, 10.1128/jvi.64.11.5324-5332.1990 Junker-Niepmann, 1990, A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA, EMBO J, 9, 3389, 10.1002/j.1460-2075.1990.tb07540.x Ueda, 1991, Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles, J Virol, 65, 3521, 10.1128/jvi.65.7.3521-3529.1991 Bruss, 1991, The role of envelope proteins in hepatitis B virus assembly, Proc Natl Acad Sci U S A, 88, 1059, 10.1073/pnas.88.3.1059 Poisson, 1997, Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle, Virology, 228, 115, 10.1006/viro.1996.8367 Bottcher, 1998, Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection, EMBO J, 17, 6839, 10.1093/emboj/17.23.6839 Penna, 1992, Fine specificity of the human T cell response to hepatitis B virus core antigen, Arch Virol Suppl, 4, 23, 10.1007/978-3-7091-5633-9_5 Chuang, 1993, Precore mutations and core clustering mutations in chronic hepatitis B virus infection, Gastroenterology, 104, 263, 10.1016/0016-5085(93)90861-6 Ehata, 1993, Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis, J Clin Invest, 91, 1206, 10.1172/JCI116281 Akarca, 1995, Naturally occurring hepatitis B virus core gene mutations, Hepatology, 22, 50 Bozkaya, 1996, High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection, Hepatology, 24, 32, 10.1002/hep.510240107 Yuan, 1999, The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen, J Virol, 73, 5731, 10.1128/JVI.73.7.5731-5740.1999 Schormann, 2006, Hepatitis B virus particle formation in the absence of pregenomic RNA and reverse transcriptase, J Virol, 80, 4187, 10.1128/JVI.80.8.4187-4190.2006 Heger-Stevic, 2018, Hepatitis B virus core protein phosphorylation: identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure, PLoS Pathog, 14, 10.1371/journal.ppat.1007488 Wu, 2019, Persistence of hepatitis B virus DNA and the tempos between virion secretion and genome maturation in a mouse model, J Virol, 93, 10.1128/JVI.01001-19 Shih, 2020, Virion secretion of hepatitis B virus naturally occurring core antigen variants, Cells, 10, 10.3390/cells10010043 Chua, 2005, Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus, J Virol, 79, 13483, 10.1128/JVI.79.21.13483-13496.2005 Yuan, 2000, A frequent, naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L), J Virol, 74, 4929, 10.1128/jvi.74.10.4929-4932.2000 Chua, 2003, Coexistence of two distinct secretion mutations (P5T and I97L) in hepatitis B virus core produces a wild-type pattern of secretion, J Virol, 77, 7673, 10.1128/JVI.77.13.7673-7676.2003 Ning, 2004, Nucleolar localization of human hepatitis B virus capsid protein, J Virol, 78, 13653, 10.1128/JVI.78.24.13653-13668.2004 Roseman, 2005, A structural model for maturation of the hepatitis B virus core, Proc Natl Acad Sci U S A, 102, 15821, 10.1073/pnas.0504874102 Bottcher, 2018, Structure of mutant hepatitis B core protein capsids with premature secretion phenotype, J Mol Biol, 430, 4941, 10.1016/j.jmb.2018.10.018 Murayama, 2019, Evaluation of in vitro screening and diagnostic kits for hepatitis B virus infection, J Clin Virol, 117, 37, 10.1016/j.jcv.2019.05.011 Iwamoto, 2014, Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP, Biochem Biophys Res Commun, 443, 808, 10.1016/j.bbrc.2013.12.052 Konig, 2019, Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells, J Hepatol, 71, 289, 10.1016/j.jhep.2019.04.010 Otoguro, 2020, Establishment of a cell culture model permissive for infection by hepatitis B and C viruses, Hepatol Commun, 5, 634, 10.1002/hep4.1653 Yamada, 2020, Anti-viral effects of interferon-lambda3 on hepatitis B virus infection in cell culture, Hepatol Res, 50, 283, 10.1111/hepr.13449 Yamada, 2017, Resistance mutations of hepatitis B virus in entecavir-refractory patients, Hepatol Commun, 1, 110, 10.1002/hep4.1022 Sugiyama, 2006, Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens, Hepatology, 44, 915, 10.1002/hep.21345 Suzuki, 2019, Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma, Hepatol Res, 49, 51, 10.1111/hepr.13277 Seitz, 2016, A slow maturation process renders hepatitis B virus infectious, Cell Host Microbe, 20, 25, 10.1016/j.chom.2016.05.013 Abe, 1999, Quantitation of hepatitis B virus genomic DNA by real-time detection PCR, J Clin Microbiol, 37, 2899, 10.1128/JCM.37.9.2899-2903.1999 Chen, 2001, Real-time PCR for detection and quantitation of hepatitis B virus DNA, J Med Virol, 65, 250, 10.1002/jmv.2027 Gunther, 1995, A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients, J Virol, 69, 5437, 10.1128/jvi.69.9.5437-5444.1995 Cai, 2013, A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures, Methods Mol Biol, 1030, 151, 10.1007/978-1-62703-484-5_13 Watashi, 2013, Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID), J Biol Chem, 288, 31715, 10.1074/jbc.M113.501122